Nifty Pharma Prediction for Tomorrow: 17 Sep 2026

September 16, 2026
Posted by: Kunal Singla
Category: Predictions

Nifty Pharma closed at 26,146.20, down 0.16%. Sun Pharmaceutical Industries gained 1.01%. India VIX 13.15.

Quick Answer: The nifty pharma prediction for tomorrow is cautiously positive for 17 September 2026. Sun Pharmaceutical Industries, a key constituent, gained 1.01 percent on 16 September 2026, tracking broader Nifty 50 direction and F&O positioning.

The nifty pharma prediction for tomorrow is in focus after Nifty Pharma closed at 26,146.20 on 16 September 2026, down 0.16 percent. Pharma stocks were roughly flat today even as sun pharma itself gained, suggesting other constituents offset that strength

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are watching sector-specific triggers here, alongside the broader Nifty 50 and Sensex direction heading into 17 September 2026.

Also read – Stock Market Predictions for Tomorrow, 17 September 2026

Table of Contents

Today’s Sector Recap

Sun Pharmaceutical Industries gained 1.01 percent, among the key movers in this space on 16 September 2026.
The broader Nifty 50 closed at 23,217.60, up 0.43 percent, setting a cautious tone across most sectors.
India VIX rose to 13.15, indicating a mild pickup in near-term volatility expectations.

Nifty Pharma F&O Outlook for Tomorrow

For traders active in F&O, this outlook will hinge on open interest build-up and rollover activity in Nifty Pharma futures and options contracts into 17 September 2026. Kunal Singla notes that a stable to falling India VIX would support range-bound F&O positioning, while a further rise could see wider intraday swings.

Key Drivers for Tomorrow

Pharma stocks were roughly flat today even as sun pharma itself gained, suggesting other constituents offset that strength
Crude oil eased sharply, down over 2.5 percent on mcx, as the market pared back some of the risk premium built into tuesday’s houthi-driven spike, a theme weighing on broader market sentiment.
Banking and fmcg stocks led a broad recovery even as it reversed hard, giving back most of the previous session’s rupee-driven bounce as the sector’s underlying us technology spending freeze reasserted itself.

Stocks to Watch for Tomorrow

Stock	CMP	Relevance
Sun Pharmaceutical Industries	See Univest Screener	Key Nifty Pharma constituent
Apollo Hospitals Enterprise	See Univest Screener	Additional Nifty Pharma name to track

Explore Nifty Pharma Stocks on Univest Screeners

Risks to This Prediction

A sharper than expected move in crude oil prices could shift sentiment across all sectors, including Nifty Pharma.
Stock-specific news flow in Sun Pharmaceutical Industries or other constituents could override the broader sector trend.
A spike in India VIX could widen intraday ranges beyond the levels discussed here.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Conclusion

The nifty pharma prediction for tomorrow leans cautiously positive into 17 September 2026, with Sun Pharmaceutical Industries and broader Nifty 50 direction as the key variables. Ankit Jaiswal and Kunal Singla will revisit this view once tomorrow’s opening trade confirms direction.

Also read – Nifty 50 Prediction for Tomorrow, 17 September 2026

Disclaimer: Investments and trades in securities and commodities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

FAQs

What is the nifty pharma prediction for tomorrow?

Ans. It is cautiously positive, based on Sun Pharmaceutical Industries’s gain of 1.01 percent on 16 September 2026 and the broader Nifty 50 trend.

Which stocks matter most for this sector’s outlook tomorrow?

Ans. Sun Pharmaceutical Industries is one of the key stocks to track, along with the broader Nifty 50 and Sensex direction.

Why was Nifty Pharma flat despite Sun Pharma’s gain?

Ans. Nifty Pharma was roughly flat today, down just 0.16 percent, despite Sun Pharma’s 1.01 percent gain, suggesting other constituents in the index offset that strength.

Should traders take F&O positions based on this outlook?

Ans. Any F&O position based on this outlook should factor in position sizing and stop-loss discipline, given the current uptick in India VIX.

News

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.